25 XP   0   0   10

Vericel Corp Ord
Buy, Hold or Sell?

Let's analyse Vericel Corp Ord together

PenkeI guess you are interested in Vericel Corp Ord. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vericel Corp Ord. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vericel Corp Ord

I send you an email if I find something interesting about Vericel Corp Ord.

Quick analysis of Vericel Corp Ord (30 sec.)










What can you expect buying and holding a share of Vericel Corp Ord? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.67
Expected worth in 1 year
$7.45
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
$2.78
Return On Investment
6.1%

For what price can you sell your share?

Current Price per Share
$45.87
Expected price per share
$41.58 - $53.05
How sure are you?
50%

1. Valuation of Vericel Corp Ord (5 min.)




Live pricePrice per Share (EOD)

$45.87

Intrinsic Value Per Share

$-2.38 - $4.87

Total Value Per Share

$2.29 - $9.54

2. Growth of Vericel Corp Ord (5 min.)




Is Vericel Corp Ord growing?

Current yearPrevious yearGrowGrow %
How rich?$225.9m$192.2m$33.6m14.9%

How much money is Vericel Corp Ord making?

Current yearPrevious yearGrowGrow %
Making money-$3.1m-$16.7m$13.5m425.1%
Net Profit Margin-1.6%-10.2%--

How much money comes from the company's main activities?

3. Financial Health of Vericel Corp Ord (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#227 / 1007

Most Revenue
#152 / 1007

Most Profit
#206 / 1007

Most Efficient
#446 / 1007

What can you expect buying and holding a share of Vericel Corp Ord? (5 min.)

Welcome investor! Vericel Corp Ord's management wants to use your money to grow the business. In return you get a share of Vericel Corp Ord.

What can you expect buying and holding a share of Vericel Corp Ord?

First you should know what it really means to hold a share of Vericel Corp Ord. And how you can make/lose money.

Speculation

The Price per Share of Vericel Corp Ord is $45.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vericel Corp Ord.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vericel Corp Ord, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.67. Based on the TTM, the Book Value Change Per Share is $0.70 per quarter. Based on the YOY, the Book Value Change Per Share is $0.45 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vericel Corp Ord.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-0.1%-0.07-0.1%-0.35-0.8%-0.14-0.3%-0.24-0.5%
Usd Book Value Change Per Share0.701.5%0.701.5%0.451.0%0.511.1%0.461.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.701.5%0.701.5%0.451.0%0.511.1%0.461.0%
Usd Price Per Share35.61-35.61-26.34-29.91-18.10-
Price to Earnings Ratio-541.43--541.43--76.27--87.53--57.88-
Price-to-Total Gains Ratio51.15-51.15-58.43-64.32-26.23-
Price to Book Ratio7.62-7.62-6.63-8.82-7.97-
Price-to-Total Gains Ratio51.15-51.15-58.43-64.32-26.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share45.87
Number of shares21
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.700.51
Usd Total Gains Per Share0.700.51
Gains per Quarter (21 shares)14.6210.74
Gains per Year (21 shares)58.4842.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10584804333
2011710608676
301751640129119
402342220172162
502922800215205
603513380258248
704093960301291
804684540344334
905265120387377
1005855700430420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%1.028.00.03.4%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%15.013.01.051.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.029.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%15.013.01.051.7%

Fundamentals of Vericel Corp Ord

About Vericel Corp Ord

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 02:35:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vericel Corp Ord.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vericel Corp Ord earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A Net Profit Margin of -1.6% means that $-0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vericel Corp Ord:

  • The MRQ is -1.6%. The company is making a loss. -1
  • The TTM is -1.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM-1.6%0.0%
TTM-1.6%YOY-10.2%+8.6%
TTM-1.6%5Y-4.2%+2.6%
5Y-4.2%10Y-19.4%+15.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.6%-207.2%+205.6%
TTM-1.6%-216.8%+215.2%
YOY-10.2%-282.4%+272.2%
5Y-4.2%-434.0%+429.8%
10Y-19.4%-584.8%+565.4%
1.1.2. Return on Assets

Shows how efficient Vericel Corp Ord is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • -0.9% Return on Assets means that Vericel Corp Ord generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vericel Corp Ord:

  • The MRQ is -0.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-0.9%0.0%
TTM-0.9%YOY-6.1%+5.2%
TTM-0.9%5Y-2.8%+1.9%
5Y-2.8%10Y-18.2%+15.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-13.2%+12.3%
TTM-0.9%-12.7%+11.8%
YOY-6.1%-11.5%+5.4%
5Y-2.8%-13.8%+11.0%
10Y-18.2%-15.5%-2.7%
1.1.3. Return on Equity

Shows how efficient Vericel Corp Ord is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • -1.4% Return on Equity means Vericel Corp Ord generated $-0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vericel Corp Ord:

  • The MRQ is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-1.4%0.0%
TTM-1.4%YOY-8.7%+7.3%
TTM-1.4%5Y-3.9%+2.5%
5Y-3.9%10Y-31.3%+27.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%-16.7%+15.3%
TTM-1.4%-15.9%+14.5%
YOY-8.7%-14.7%+6.0%
5Y-3.9%-19.2%+15.3%
10Y-31.3%-20.0%-11.3%

1.2. Operating Efficiency of Vericel Corp Ord.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vericel Corp Ord is operating .

  • Measures how much profit Vericel Corp Ord makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • An Operating Margin of -3.3% means the company generated $-0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vericel Corp Ord:

  • The MRQ is -3.3%. The company is operating very inefficient. -2
  • The TTM is -3.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3.3%TTM-3.3%0.0%
TTM-3.3%YOY-10.4%+7.1%
TTM-3.3%5Y-5.5%+2.3%
5Y-5.5%10Y-21.2%+15.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.3%-298.0%+294.7%
TTM-3.3%-238.5%+235.2%
YOY-10.4%-291.9%+281.5%
5Y-5.5%-485.6%+480.1%
10Y-21.2%-610.8%+589.6%
1.2.2. Operating Ratio

Measures how efficient Vericel Corp Ord is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.03 means that the operating costs are $1.03 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vericel Corp Ord:

  • The MRQ is 1.033. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.033. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.033TTM1.0330.000
TTM1.033YOY1.104-0.071
TTM1.0335Y1.053-0.020
5Y1.05310Y1.199-0.146
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0333.235-2.202
TTM1.0333.310-2.277
YOY1.1043.791-2.687
5Y1.0535.675-4.622
10Y1.1997.558-6.359

1.3. Liquidity of Vericel Corp Ord.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vericel Corp Ord is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.49 means the company has $4.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vericel Corp Ord:

  • The MRQ is 4.495. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.495. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.495TTM4.4950.000
TTM4.495YOY4.988-0.493
TTM4.4955Y5.340-0.846
5Y5.34010Y4.743+0.597
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4953.877+0.618
TTM4.4954.178+0.317
YOY4.9885.343-0.355
5Y5.3406.135-0.795
10Y4.7436.468-1.725
1.3.2. Quick Ratio

Measures if Vericel Corp Ord is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A Quick Ratio of 4.94 means the company can pay off $4.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vericel Corp Ord:

  • The MRQ is 4.943. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.943. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.943TTM4.9430.000
TTM4.943YOY6.261-1.317
TTM4.9435Y6.410-1.466
5Y6.41010Y5.554+0.856
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9433.514+1.429
TTM4.9433.998+0.945
YOY6.2615.380+0.881
5Y6.4106.135+0.275
10Y5.5546.434-0.880

1.4. Solvency of Vericel Corp Ord.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vericel Corp Ord assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vericel Corp Ord to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Vericel Corp Ord assets are financed with 36.1% credit (debt) and the remaining percentage (100% - 36.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vericel Corp Ord:

  • The MRQ is 0.361. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.361. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.361TTM0.3610.000
TTM0.361YOY0.296+0.065
TTM0.3615Y0.316+0.045
5Y0.31610Y0.340-0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3610.339+0.022
TTM0.3610.336+0.025
YOY0.2960.271+0.025
5Y0.3160.368-0.052
10Y0.3400.388-0.048
1.4.2. Debt to Equity Ratio

Measures if Vericel Corp Ord is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A Debt to Equity ratio of 56.5% means that company has $0.57 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vericel Corp Ord:

  • The MRQ is 0.565. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.565. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.565TTM0.5650.000
TTM0.565YOY0.420+0.145
TTM0.5655Y0.465+0.100
5Y0.46510Y0.576-0.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5650.388+0.177
TTM0.5650.403+0.162
YOY0.4200.340+0.080
5Y0.4650.430+0.035
10Y0.5760.463+0.113

2. Market Valuation of Vericel Corp Ord

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vericel Corp Ord generates.

  • Above 15 is considered overpriced but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A PE ratio of -541.43 means the investor is paying $-541.43 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vericel Corp Ord:

  • The EOD is -697.427. Based on the earnings, the company is expensive. -2
  • The MRQ is -541.430. Based on the earnings, the company is expensive. -2
  • The TTM is -541.430. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-697.427MRQ-541.430-155.997
MRQ-541.430TTM-541.4300.000
TTM-541.430YOY-76.267-465.163
TTM-541.4305Y-87.530-453.900
5Y-87.53010Y-57.880-29.650
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-697.427-2.281-695.146
MRQ-541.430-2.599-538.831
TTM-541.430-2.674-538.756
YOY-76.267-4.133-72.134
5Y-87.530-6.258-81.272
10Y-57.880-6.270-51.610
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vericel Corp Ord:

  • The EOD is 284.588. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 220.932. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 220.932. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD284.588MRQ220.932+63.655
MRQ220.932TTM220.9320.000
TTM220.932YOY126.285+94.647
TTM220.9325Y90.255+130.678
5Y90.25510Y14.056+76.198
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD284.588-2.903+287.491
MRQ220.932-3.323+224.255
TTM220.932-3.552+224.484
YOY126.285-5.592+131.877
5Y90.255-8.378+98.633
10Y14.056-8.875+22.931
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vericel Corp Ord is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.62 means the investor is paying $7.62 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vericel Corp Ord:

  • The EOD is 9.822. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.625. Based on the equity, the company is overpriced. -1
  • The TTM is 7.625. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.822MRQ7.625+2.197
MRQ7.625TTM7.6250.000
TTM7.625YOY6.628+0.997
TTM7.6255Y8.822-1.198
5Y8.82210Y7.969+0.854
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.8221.911+7.911
MRQ7.6252.116+5.509
TTM7.6252.097+5.528
YOY6.6282.885+3.743
5Y8.8223.556+5.266
10Y7.9693.959+4.010
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vericel Corp Ord.

3.1. Institutions holding Vericel Corp Ord

Institutions are holding 110.743% of the shares of Vericel Corp Ord.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc16.40550.007279370634596696.1474
2023-12-31Brown Capital Management, LLC14.09443.64356818933-60621-0.8812
2023-12-31Vanguard Group Inc6.97410.00263374093485141.4588
2023-12-31RTW INVESTMENTS, LLC6.64071.78713212794-79079-2.4022
2023-12-31State Street Corporation5.50820.00462664883-28780-1.0684
2023-12-31Conestoga Capital Advisors, LLC4.83661.250423399601092154.8959
2023-12-31GW&K Investment Management, LLC2.73520.43941323306-46128-3.3684
2023-12-31Morgan Stanley - Brokerage Accounts2.68260.00411297846-58580-4.3187
2023-12-31Macquarie Group Ltd2.36910.04721146193-27984-2.3833
2023-12-31Loomis, Sayles & Company LP2.35950.06231141526-36134-3.0683
2023-12-31New York State Common Retirement Fund2.1930.05231060965-30717-2.8137
2023-12-31Geode Capital Management, LLC2.12350.00381027379501615.133
2023-12-31Goldman Sachs Group Inc1.9520.00394439046141695.5364
2023-12-31BNP Paribas Investment Partners SA1.90350.0913920898-2317-0.251
2023-12-31William Blair Investment Management, LLC1.72570.0865834885-20322-2.3763
2023-12-31Dimensional Fund Advisors, Inc.1.50980.007673042680801.1186
2023-12-31JPMorgan Chase & Co1.42960.0024691630609449.6631
2023-12-31Ameriprise Financial Inc1.39570.0072675222-38792-5.4329
2023-09-30Point72 Asset Management, L.P.1.27650.060461759811671223.3011
2023-12-31Nuveen Asset Management, LLC1.25440.00760690444990.7468
Total 81.36967.569939366894+889756+2.3%

3.2. Funds holding Vericel Corp Ord

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Brown Capital Mgmt Small Co Inv7.99783.7895386938100
2024-03-28iShares Core S&P Small-Cap ETF6.66230.20873223240-11607-0.3588
2024-02-29Conestoga Small Cap Investors3.33231.81471612200177501.1132
2024-02-29Vanguard Total Stock Mkt Idx Inv3.09170.00441495786-5710-0.3803
2024-03-28SPDR® S&P Biotech ETF2.96810.98931435995181201.278
2024-03-28iShares Russell 2000 ETF2.41640.0929116908181160.6991
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.44930.031470117925810.3695
2023-12-31Conestoga Small Cap Growth1.41651.4981685299211603.1861
2024-02-29Delaware Ivy Small Cap Growth C1.35582.1109655928-87532-11.7736
2024-02-29Loomis Sayles Small Cap Growth Instl1.33141.2833644126-17331-2.6201
2024-01-31Fidelity Small Cap Growth1.30650.473963206820374947.5695
2024-02-29BNP Paribas Health Cr Innovtr Cl Cap1.29551.6527626765199763.2921
2024-01-31Fidelity Small Cap Index0.99650.083648210072391.5244
2024-03-28iShares S&P Small-Cap 600 Growth ETF0.96430.410646651700
2024-02-29JPM Thematics Genetic Thrps C2 Acc USD0.93832.6916453972-6868-1.4903
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.8730.20894223574350.1031
2024-03-28iShares Russell 2000 Growth ETF0.85370.1844413046-480-0.1161
2024-02-29Congress Small Cap Growth Institutional0.82681.81244000004000000
2024-02-29Vanguard Tax-Managed Small Cap Adm0.77070.191737285700
2024-03-28iShares Biotechnology ETF0.73560.242635589600
Total 41.582519.775620117793+569598+2.8%

3.3. Insider Transactions

Insiders are holding 0.832% of the shares of Vericel Corp Ord.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-27Robert L Md ZerbeSELL327851.57
2024-03-13Dominick ColangeloSELL1750044.67
2024-03-11Michael HalpinSELL787444.71
2024-03-08Sean C FlynnSELL811545.33
2024-01-29Robert L Md ZerbeSELL230044.22
2024-01-25Robert L Md ZerbeSELL20044.02
2024-01-22Robert L Md ZerbeSELL800041.85
2024-01-18Dominick ColangeloSELL1672638.58
2024-01-12Robert L Md ZerbeSELL220038.09
2023-07-14Robert L Md ZerbeSELL100038.84
2023-06-22Robert L Md ZerbeSELL300036

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vericel Corp Ord compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6960.6960%0.451+54%0.511+36%0.459+52%
Book Value Per Share--4.6704.6700%3.974+18%3.448+35%2.152+117%
Current Ratio--4.4954.4950%4.988-10%5.340-16%4.743-5%
Debt To Asset Ratio--0.3610.3610%0.296+22%0.316+14%0.340+6%
Debt To Equity Ratio--0.5650.5650%0.420+35%0.465+22%0.576-2%
Dividend Per Share----0%-0%-0%-0%
Eps---0.066-0.0660%-0.345+425%-0.141+115%-0.239+263%
Free Cash Flow Per Share--0.1610.1610%0.209-23%0.183-12%-0.076+147%
Free Cash Flow To Equity Per Share--0.2360.2360%0.230+3%0.288-18%0.301-22%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.868--------
Intrinsic Value_10Y_min---2.382--------
Intrinsic Value_1Y_max--0.317--------
Intrinsic Value_1Y_min---0.118--------
Intrinsic Value_3Y_max--1.082--------
Intrinsic Value_3Y_min---0.462--------
Intrinsic Value_5Y_max--2.004--------
Intrinsic Value_5Y_min---0.920--------
Market Cap2219213535.000+22%1722829605.0001722829605.0000%1274342370.000+35%1446867233.000+19%875687050.000+97%
Net Profit Margin---0.016-0.0160%-0.102+531%-0.042+160%-0.194+1105%
Operating Margin---0.033-0.0330%-0.104+217%-0.055+69%-0.212+549%
Operating Ratio--1.0331.0330%1.104-6%1.053-2%1.199-14%
Pb Ratio9.822+22%7.6257.6250%6.628+15%8.822-14%7.969-4%
Pe Ratio-697.427-29%-541.430-541.4300%-76.267-86%-87.530-84%-57.880-89%
Price Per Share45.870+22%35.61035.6100%26.340+35%29.906+19%18.100+97%
Price To Free Cash Flow Ratio284.588+22%220.932220.9320%126.285+75%90.255+145%14.056+1472%
Price To Total Gains Ratio65.891+22%51.15351.1530%58.429-12%64.320-20%26.227+95%
Quick Ratio--4.9434.9430%6.261-21%6.410-23%5.554-11%
Return On Assets---0.009-0.0090%-0.061+580%-0.028+208%-0.182+1924%
Return On Equity---0.014-0.0140%-0.087+517%-0.039+176%-0.313+2123%
Total Gains Per Share--0.6960.6960%0.451+54%0.511+36%0.459+52%
Usd Book Value--225952000.000225952000.0000%192272000.000+18%166807400.000+35%104128800.000+117%
Usd Book Value Change Per Share--0.6960.6960%0.451+54%0.511+36%0.459+52%
Usd Book Value Per Share--4.6704.6700%3.974+18%3.448+35%2.152+117%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.066-0.0660%-0.345+425%-0.141+115%-0.239+263%
Usd Free Cash Flow--7798000.0007798000.0000%10091000.000-23%8832200.000-12%-3694100.000+147%
Usd Free Cash Flow Per Share--0.1610.1610%0.209-23%0.183-12%-0.076+147%
Usd Free Cash Flow To Equity Per Share--0.2360.2360%0.230+3%0.288-18%0.301-22%
Usd Market Cap2219213535.000+22%1722829605.0001722829605.0000%1274342370.000+35%1446867233.000+19%875687050.000+97%
Usd Price Per Share45.870+22%35.61035.6100%26.340+35%29.906+19%18.100+97%
Usd Profit---3182000.000-3182000.0000%-16709000.000+425%-6481400.000+104%-11365600.000+257%
Usd Revenue--197516000.000197516000.0000%164365000.000+20%152018800.000+30%104922200.000+88%
Usd Total Gains Per Share--0.6960.6960%0.451+54%0.511+36%0.459+52%
 EOD+5 -3MRQTTM+0 -0YOY+22 -115Y+21 -1210Y+26 -7

4.2. Fundamental Score

Let's check the fundamental score of Vericel Corp Ord based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-697.427
Price to Book Ratio (EOD)Between0-19.822
Net Profit Margin (MRQ)Greater than0-0.016
Operating Margin (MRQ)Greater than0-0.033
Quick Ratio (MRQ)Greater than14.943
Current Ratio (MRQ)Greater than14.495
Debt to Asset Ratio (MRQ)Less than10.361
Debt to Equity Ratio (MRQ)Less than10.565
Return on Equity (MRQ)Greater than0.15-0.014
Return on Assets (MRQ)Greater than0.05-0.009
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Vericel Corp Ord based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.987
Ma 20Greater thanMa 5047.561
Ma 50Greater thanMa 10047.206
Ma 100Greater thanMa 20043.252
OpenGreater thanClose46.040
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets353,657
Total Liabilities127,705
Total Stockholder Equity225,952
 As reported
Total Liabilities 127,705
Total Stockholder Equity+ 225,952
Total Assets = 353,657

Assets

Total Assets353,657
Total Current Assets205,631
Long-term Assets148,026
Total Current Assets
Cash And Cash Equivalents 86,866
Short-term Investments 40,469
Net Receivables 58,356
Inventory 13,087
Other Current Assets 6,853
Total Current Assets  (as reported)205,631
Total Current Assets  (calculated)205,631
+/-0
Long-term Assets
Property Plant Equipment 115,097
Long Term Investments 25,283
Intangible Assets 6,875
Long-term Assets Other 771
Long-term Assets  (as reported)148,026
Long-term Assets  (calculated)148,026
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities45,749
Long-term Liabilities81,956
Total Stockholder Equity225,952
Total Current Liabilities
Short-term Debt 6,187
Accounts payable 22,347
Other Current Liabilities 17,215
Total Current Liabilities  (as reported)45,749
Total Current Liabilities  (calculated)45,749
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt81,856
Long-term Liabilities Other 100
Long-term Liabilities  (as reported)81,956
Long-term Liabilities  (calculated)81,956
+/- 0
Total Stockholder Equity
Common Stock629,229
Retained Earnings -403,177
Accumulated Other Comprehensive Income -100
Total Stockholder Equity (as reported)225,952
Total Stockholder Equity (calculated)225,952
+/-0
Other
Capital Stock629,229
Cash and Short Term Investments 127,335
Common Stock Shares Outstanding 47,590
Liabilities and Stockholders Equity 353,657
Net Debt 1,277
Net Invested Capital 225,952
Net Working Capital 159,882
Property Plant and Equipment Gross 137,303
Short Long Term Debt Total 88,143



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-31
> Total Assets 
12,700
18,400
18,400
12,374
9,540
13,437
11,905
11,553
12,155
18,166
33,897
44,881
32,848
26,217
19,276
32,827
7,739
15,178
9,215
47,579
34,309
48,598
54,577
118,689
153,238
205,608
243,705
273,003
353,657
353,657273,003243,705205,608153,238118,68954,57748,59834,30947,5799,21515,1787,73932,82719,27626,21732,84844,88133,89718,16612,15511,55311,90513,4379,54012,37418,40018,40012,700
   > Total Current Assets 
11,500
17,400
17,400
11,649
9,038
13,145
11,726
11,347
11,853
17,832
33,144
43,665
30,177
24,063
17,791
31,699
6,175
13,990
8,476
41,490
27,343
44,723
50,506
112,783
111,655
123,560
158,462
186,866
205,631
205,631186,866158,462123,560111,655112,78350,50644,72327,34341,4908,47613,9906,17531,69917,79124,06330,17743,66533,14417,83211,85311,34711,72613,1459,03811,64917,40017,40011,500
       Cash And Cash Equivalents 
11,000
1,900
1,900
2,078
7,528
2,064
10,659
8,605
10,512
16,926
14,408
9,034
13,439
16,492
17,000
31,248
5,530
13,638
8,059
30,343
14,581
22,978
26,862
18,286
26,889
33,620
68,330
51,067
86,866
86,86651,06768,33033,62026,88918,28626,86222,97814,58130,3438,05913,6385,53031,24817,00016,49213,4399,03414,40816,92610,5128,60510,6592,0647,5282,0781,9001,90011,000
       Short-term Investments 
0
0
9,134
9,134
10,681
10,681
1,000
1,000
0
18,006
18,006
33,963
14,886
5,970
5,000
5,000
0
0
0
0
0
0
0
64,638
42,829
42,187
35,068
68,471
40,469
40,46968,47135,06842,18742,82964,63800000005,0005,0005,97014,88633,96318,00618,00601,0001,00010,68110,6819,1349,13400
       Net Receivables 
100
200
200
167
113
242
129
120
350
246
193
139
78
18
58
25
9
28
0
8,191
10,919
17,093
18,270
23,454
32,168
34,504
37,437
46,539
58,356
58,35646,53937,43734,50432,16823,45418,27017,09310,9198,191028925581878139193246350120129242113167200200100
       Other Current Assets 
400
15,300
15,300
270
253
158
213
225
185
271
421
528
1,766
1,583
732
426
636
324
417
1,036
464
1,164
1,581
2,847
2,953
3,893
4,246
4,803
6,853
6,8534,8034,2463,8932,9532,8471,5811,1644641,0364173246364267321,5831,76652842127118522521315825327015,30015,300400
   > Long-term Assets 
1,200
1,000
1,000
725
502
292
179
206
302
334
753
1,216
2,671
2,154
1,485
1,128
1,564
1,188
739
6,089
6,966
3,875
4,071
5,906
41,583
82,048
85,243
86,137
148,026
148,02686,13785,24382,04841,5835,9064,0713,8756,9666,0897391,1881,5641,1281,4852,1542,6711,2167533343022061792925027251,0001,0001,200
       Property Plant Equipment 
1,200
1,000
1,000
725
502
292
179
206
302
334
753
1,216
2,671
2,154
1,485
1,128
1,564
1,188
739
2,892
4,049
3,875
4,071
5,906
32,247
57,738
59,028
57,372
115,097
115,09757,37259,02857,73832,2475,9064,0713,8754,0492,8927391,1881,5641,1281,4852,1542,6711,2167533343022061792925027251,0001,0001,200
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,247
24,099
25,687
19,962
25,283
25,28319,96225,68724,0999,247000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,197
2,917
0
0
0
0
0
0
7,500
6,875
6,8757,5000000002,9173,1970000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
57,919
528
1,303
0
01,30352857,91989000000000000000000000000
> Total Liabilities 
36,100
1,800
1,800
1,528
1,029
1,002
1,011
750
580
558
869
2,539
4,597
2,883
1,992
29,905
20,710
5,665
5,321
11,938
12,179
23,889
32,037
16,458
42,147
71,348
73,243
80,731
127,705
127,70580,73173,24371,34842,14716,45832,03723,88912,17911,9385,3215,66520,71029,9051,9922,8834,5972,5398695585807501,0111,0021,0291,5281,8001,80036,100
   > Total Current Liabilities 
1,600
1,800
1,800
1,528
1,029
1,002
1,011
750
580
558
869
2,539
3,500
2,100
1,687
29,864
20,670
5,659
5,321
11,829
12,108
12,852
13,090
14,792
19,795
22,483
26,052
37,463
45,749
45,74937,46326,05222,48319,79514,79213,09012,85212,10811,8295,3215,65920,67029,8641,6872,1003,5002,5398695585807501,0111,0021,0291,5281,8001,8001,600
       Short-term Debt 
200
100
100
65
0
0
0
0
0
0
0
439
439
446
479
214
40
34
6
109
71
779
350
0
5,461
4,394
2,950
4,302
6,187
6,1874,3022,9504,3945,46103507797110963440214479446439439000000065100100200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109
71
779
350
0
0
0
0
0
0
000000350779711090000000000000000000
       Accounts payable 
1,200
1,500
1,500
1,313
836
837
856
589
406
382
533
356
532
907
973
0
2,239
2,843
2,355
5,824
7,588
6,534
5,552
7,108
6,345
6,755
9,016
16,930
22,347
22,34716,9309,0166,7556,3457,1085,5526,5347,5885,8242,3552,8432,23909739075323565333824065898568378361,3131,5001,5001,200
       Other Current Liabilities 
200
200
200
150
193
165
155
161
174
176
336
2,183
2,529
747
1,208
29,650
16,625
1,995
2,019
6,005
4,520
1,016
1,195
7,684
41
41
41
16,231
17,215
17,21516,2314141417,6841,1951,0164,5206,0052,0191,99516,62529,6501,2087472,5292,183336176174161155165193150200200200
   > Long-term Liabilities 
34,500
100
100
1,378
836
837
856
589
406
382
533
356
1,097
783
305
41
40
6
2,361
109
71
11,037
18,947
1,666
22,352
48,865
47,191
43,268
81,956
81,95643,26847,19148,86522,3521,66618,94711,037711092,361640413057831,0973565333824065898568378361,37810010034,500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40
0
0
0
71
32
16,888
0
110
0
0
0
0
0000110016,8883271000400000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104
0
0
0
0
0
0000010400000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,687
2,059
1,502
0
0
44
0
0
0044001,5022,0591,687000000000000000000000
> Total Stockholder Equity
-23,400
16,600
16,600
10,846
8,511
12,435
10,894
10,803
11,575
17,608
33,028
42,342
28,251
23,334
17,284
2,922
-12,971
9,513
3,894
35,641
22,130
24,709
22,540
102,231
111,091
134,260
170,462
192,272
225,952
225,952192,272170,462134,260111,091102,23122,54024,70922,13035,6413,8949,513-12,9712,92217,28423,33428,25142,34233,02817,60811,57510,80310,89412,4358,51110,84616,60016,600-23,400
   Common Stock
0
0
59,474
59,474
72,257
92,367
96,752
104,600
114,951
131,472
158,703
184,492
187,995
203,211
213,107
231,343
228,877
243,215
253,270
305,008
307,766
329,721
383,020
471,180
489,749
510,061
553,902
593,245
629,229
629,229593,245553,902510,061489,749471,180383,020329,721307,766305,008253,270243,215228,877231,343213,107203,211187,995184,492158,703131,472114,951104,60096,75292,36772,25759,47459,47400
   Retained Earnings -403,177-399,995-383,286-375,815-378,679-369,014-360,877-343,591-324,025-307,685-287,765-275,315-241,848-222,180-195,823-179,877-159,744-142,150-125,675-113,864-103,376-93,797-85,858-79,932-70,334-58,897-41,300-41,300-27,000
   Accumulated Other Comprehensive Income 
-1,200
-1,700
-1,700
339
-2,480
-2,819
-2,862
-2,932
-3,040
-3,165
-2,192
-2,503
-1,940
-2,644
-3,115
-3,652
-4,135
-3,598
-4,087
-71
-5,638
-7,093
-6,621
-39
21
14
-154
-978
-100
-100-978-1541421-39-6,621-7,093-5,638-71-4,087-3,598-4,135-3,652-3,115-2,644-1,940-2,503-2,192-3,165-3,040-2,932-2,862-2,819-2,480339-1,700-1,700-1,200
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000-3,15000000000000000000000
   Other Stockholders Equity 
4,800
59,600
59,600
9,068
2,480
2,819
2,862
2,932
3,040
3,165
2,192
186,995
189,935
205,855
216,222
-6,241
228,877
3,598
4,087
38,389
2,488
7,283
7,018
104
21
127,614
177,933
592,267
0
0592,267177,933127,614211047,0187,2832,48838,3894,0873,598228,877-6,241216,222205,855189,935186,9952,1923,1653,0402,9322,8622,8192,4809,06859,60059,6004,800



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue197,516
Cost of Revenue-61,940
Gross Profit135,576135,576
 
Operating Income (+$)
Gross Profit135,576
Operating Expense-142,040
Operating Income-6,464-6,464
 
Operating Expense (+$)
Research Development21,042
Selling General Administrative117,042
Selling And Marketing Expenses0
Operating Expense142,040138,084
 
Net Interest Income (+$)
Interest Income3,959
Interest Expense-600
Other Finance Cost-67
Net Interest Income3,292
 
Pretax Income (+$)
Operating Income-6,464
Net Interest Income3,292
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,368-10,560
EBIT - interestExpense = -7,064
-2,368
-2,582
Interest Expense600
Earnings Before Interest and Taxes (EBIT)-6,464-1,768
Earnings Before Interest and Taxes (EBITDA)-1,832
 
After tax Income (+$)
Income Before Tax-2,368
Tax Provision-414
Net Income From Continuing Ops-10,253-2,782
Net Income-3,182
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses203,980
Total Other Income/Expenses Net4,096-3,292
 

Technical Analysis of Vericel Corp Ord
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vericel Corp Ord. The general trend of Vericel Corp Ord is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vericel Corp Ord's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vericel Corp Ord.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 53.05.

The bearish price targets are: 43.48 > 42.38 > 41.58.

Tweet this
Vericel Corp Ord Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vericel Corp Ord. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vericel Corp Ord Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vericel Corp Ord. The current macd is -0.55246178.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vericel Corp Ord price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vericel Corp Ord. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vericel Corp Ord price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Vericel Corp Ord Daily Moving Average Convergence/Divergence (MACD) ChartVericel Corp Ord Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vericel Corp Ord. The current adx is 23.74.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vericel Corp Ord shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vericel Corp Ord Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vericel Corp Ord. The current sar is 42.47.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vericel Corp Ord Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vericel Corp Ord. The current rsi is 44.99. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Vericel Corp Ord Daily Relative Strength Index (RSI) ChartVericel Corp Ord Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vericel Corp Ord. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vericel Corp Ord price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vericel Corp Ord Daily Stochastic Oscillator ChartVericel Corp Ord Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vericel Corp Ord. The current cci is -56.69440414.

Vericel Corp Ord Daily Commodity Channel Index (CCI) ChartVericel Corp Ord Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vericel Corp Ord. The current cmo is -12.67004351.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Vericel Corp Ord Daily Chande Momentum Oscillator (CMO) ChartVericel Corp Ord Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vericel Corp Ord. The current willr is -52.87915762.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vericel Corp Ord is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vericel Corp Ord Daily Williams %R ChartVericel Corp Ord Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vericel Corp Ord.

Vericel Corp Ord Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vericel Corp Ord. The current atr is 1.57782396.

Vericel Corp Ord Daily Average True Range (ATR) ChartVericel Corp Ord Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vericel Corp Ord. The current obv is 10,946,539.

Vericel Corp Ord Daily On-Balance Volume (OBV) ChartVericel Corp Ord Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vericel Corp Ord. The current mfi is 40.37.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Vericel Corp Ord Daily Money Flow Index (MFI) ChartVericel Corp Ord Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vericel Corp Ord.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Vericel Corp Ord Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vericel Corp Ord based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.987
Ma 20Greater thanMa 5047.561
Ma 50Greater thanMa 10047.206
Ma 100Greater thanMa 20043.252
OpenGreater thanClose46.040
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vericel Corp Ord with someone you think should read this too:
  • Are you bullish or bearish on Vericel Corp Ord? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vericel Corp Ord? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vericel Corp Ord

I send you an email if I find something interesting about Vericel Corp Ord.


Comments

How you think about this?

Leave a comment

Stay informed about Vericel Corp Ord.

Receive notifications about Vericel Corp Ord in your mailbox!